INFECTION SURVEILLANCE
+ Antimicrobial Stewardship programs
NEW AMS CLINICAL ABSTRACT:
Dr. Chris Morgan analyzes 4,071 full panel respiratory PCR Tests in 56 LTC facilities identifying a concern of antibiotic gene resistance. Learn what pathogens are in your facility and how to reduce infection rates and growing risk of MDROs.
Comprehensive and Targeted Infection Surveillance & Antimicrobial Stewardship Programs
Solving Critical Infection Prevention Issues
Supported by a group of clinical leaders with a combined 75+ years specializing in Infection Prevention and Control, AMS’ clinical practice builds and maintains comprehensive Infection Surveillance programs. Our services help minimize infection risk in long-term care, as well as in the government and industry work-place.
INFECTION SURVEILLANCE
The AMS approach to reducing infection risks and helping facilities stay F880 compliant is proven and highly effective. We understand the challenges facing long-term care and have a partnership platform that requires very little extra staff time. We serve and support staff by providing useful insights and expertise. AMS employs a combination of continuous and on-going infection prevention mentorship supported by laboratory diagnostics and infectious disease analytics.
AMS provides both Targeted and Comprehensive Infection Surveillance that mitigate infection risk early and often. Your clinical leadership chooses which is best for your resident population.
COMPREHENSIVE SURVEILLANCE
Sterisis
- Identifies all infection risks among all residents; conducted quarterly
- PCR-based diagnostics targets 37 respiratory pathogens and an antibiotic gene resistance test
- Unique infectious disease analytics prioritizes infection risks and provides both clinical care and QA improvement recommendations
- Certified Infection Preventionists provide continuous education and mentorship
COMPREHENSIVE SURVEILLANCE
Pinpoint
- Generally focused on symptomatic residents only
- Employs a “Decision Tree”: PCR-based testing model beginning with COVID-19; if negative, then to respiratory viral pathogens; if negative, then to full respiratory panel testing including an antibiotic gene resistance test; if still negative, then contact the medical director with other testing recommendations
- Certified Infection Preventionists provide continuous education and mentorship
*Note: Facilities that choose Pinpoint must choose AMS lab partners for their COVID-19 testing
ADDITIONAL SERVICES
COMPREHENSIVE SURVEILLANCE
Virtual Rounding
- AMS clinicians review resident EMRs and documentation daily
- Highlight residents in need of clinical prioritization
- Proposed recommendations based on EMR data, analytics, test results
- Monitor and alert facility for possible trending infections
- Highlights potential documentation errors to ensure compliance with regulations
- Access to AMS doctors, IPs, DONs, RNs, and LPNs